Search results
Results From The WOW.Com Content Network
Alcon offices in Johns Creek, Georgia. Alcon Inc. ( German: Alcon AG) is a Swiss-American pharmaceutical and medical device company specializing in eye care products. It has a paper headquarters in Geneva, Switzerland but its operational headquarters are in Fort Worth, Texas, United States, where it employs about 4,500 people. [2]
Alcon Entertainment, LLC is an American independent film and television production company, founded in 1997 by film producers Broderick Johnson and Andrew Kosove.Since its establishment, Alcon Entertainment has developed and financed films that are ultimately distributed – in the United States mostly, and internationally on occasion – by Warner Bros. Pictures, following a ten-year motion ...
The US Food and Drug Administration (FDA) defines soft contact lenses as: made of soft, flexible plastics that allow oxygen to pass through to the cornea. Soft contact lenses may be easier to adjust to and are more comfortable than rigid gas permeable lenses. Newer soft lens materials include silicone-hydrogels to provide more oxygen to your ...
The global company based in Switzerland operates in 60 countries and serve patients in more than 140 countries. Alcon’s most recent earnings report projects close to $9.5 billion in net sales in ...
The search engine that helps you find exactly what you're looking for. Find the most relevant information, video, images, and answers from all across the Web.
Nepafenac, sold under the brand name Nevanac among others, is a nonsteroidal anti-inflammatory drug (NSAID), usually sold as a prescription eye drop 0.1% solution (Nevanac) or 0.3% solution (Ilevro). It is used to treat pain and inflammation associated with cataract surgery. [ 3] Nepafenac is a prodrug of amfenac, an inhibitor of COX-1 and COX ...
For premium support please call: 800-290-4726 more ways to reach us
Finafloxacin is the first FDA approved medication in the United States that was first developed by a Singaporean drug company. Finafloxacin was officially approved by the FDA on December 17, 2014. The company, MerLion Pharmaceuticals, partnered with the North American company Alcon to produce the drug commercially in the United States.